| Year |
Citation |
Score |
| 2021 |
Stiffel M, Bergeron D, Mourabit Amari K, Poulin É, Roberge X, Meilleur-Durand S, Sellami L, Molin P, Nadeau Y, Fortin MP, Caron S, Poulin S, Verret L, Bouchard RW, Teunissen C, et al. Use of Alzheimer's disease cerebrospinal fluid biomarkers in a tertiary-care memory clinic. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1-23. PMID 33845924 DOI: 10.1017/cjn.2021.67 |
0.67 |
|
| 2020 |
Gravel A, Hudon C, Meilleur-Durand S, Sellami L, Bergeron D, Paradis A, Verret L, Fortin MP, Poulin S, Macoir J, Bouchard RW, Laforce R. Validation of the Dépistage Cognitif de Québec in the Oldest Old. Canadian Geriatrics Journal : Cgj. 23: 283-288. PMID 33282048 DOI: 10.5770/cgj.23.432 |
0.693 |
|
| 2020 |
Bergeron D, Sellami L, Poulin S, Verret L, Bouchard RW, Laforce R. The Behavioral/Dysexecutive Variant of Alzheimer's Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization. Dementia and Geriatric Cognitive Disorders. 1-8. PMID 33207355 DOI: 10.1159/000511210 |
0.701 |
|
| 2020 |
Montreuil S, Poulin E, Bergeron D, Sellami L, Verret L, Fortin MP, Poulin S, Macoir J, Hudon C, Bouchard RW, Lavoie M, Laforce R. Cognitive Profile of the Logopenic Variant of Primary Progressive Aphasia Using the Dépistage Cognitif de Québec. Dementia and Geriatric Cognitive Disorders. 1-8. PMID 33113530 DOI: 10.1159/000510501 |
0.708 |
|
| 2020 |
Bergeron D, Beauregard JM, Soucy JP, Verret L, Poulin S, Matias-Guiu JA, Cabrera-Martín MN, Bouchard RW, Laforce R. Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32925054 DOI: 10.3233/Jad-200567 |
0.694 |
|
| 2018 |
Sellami L, Meilleur-Durand S, Chouinard AM, Bergeron D, Verret L, Poulin S, Jean L, Fortin MP, Nadeau Y, Molin P, Caron S, Macoir J, Hudon C, Bouchard RW, Laforce R. The Dépistage Cognitif de Québec: A New Clinician's Tool for Early Recognition of Atypical Dementia. Dementia and Geriatric Cognitive Disorders. 46: 310-321. PMID 30481754 DOI: 10.1159/000494348 |
0.749 |
|
| 2018 |
Bergeron D, Gorno-Tempini ML, Rabinovici GD, Santos-Santos MA, Seeley W, Miller BL, Pijnenburg Y, Keulen MA, Groot C, van Berckel BNM, van der Flier WM, Scheltens P, Rohrer JD, Warren JD, Schott JM, ... ... Bouchard RW, et al. Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia. Annals of Neurology. PMID 30255971 DOI: 10.1002/Ana.25333 |
0.651 |
|
| 2017 |
Bernier PJ, Gourdeau C, Carmichael PH, Beauchemin JP, Verreault R, Bouchard RW, Kröger E, Laforce R. Validation and diagnostic accuracy of predictive curves for age-associated longitudinal cognitive decline in older adults. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 189: E1472-E1480. PMID 29203616 DOI: 10.1503/Cmaj.160792 |
0.701 |
|
| 2017 |
Laforce R, Sellami L, Bergeron D, Paradis A, Verret L, Fortin MP, Houde M, Roy M, Poulin S, Macoir J, Hudon C, Bouchard RW. Validation of the Dépistage Cognitif de Québec: A New Cognitive Screening Tool for Atypical Dementias. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 1-9. PMID 28541543 DOI: 10.1093/Arclin/Acx048 |
0.744 |
|
| 2017 |
Bergeron D, Flynn K, Verret L, Poulin S, Bouchard RW, Bocti C, Fülöp T, Lacombe G, Gauthier S, Nasreddine Z, Jr Laforce R. Multicenter Validation of an MMSE-MoCA Conversion Table. Journal of the American Geriatrics Society. PMID 28205215 DOI: 10.1111/Jgs.14779 |
0.717 |
|
| 2017 |
Bergeron D, Vermette A, De La Sablonnière J, Cayer A, Bouchard RW, Laforce R. [P1-332]: HIDDEN IN PLAIN SIGHT: COGNITIVE INTERPRETATION OF THE FINGER-TO-NOSE TEST IN ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P383-P383. DOI: 10.1016/J.Jalz.2017.06.348 |
0.644 |
|
| 2017 |
Bergeron D, Sellami L, Verret L, Fortin M, Houde M, Hudon C, Poulin S, Roy M, Bouchard RW, Laforce R. [P2-445]: DÉ́PISTAGE COGNITIF DE QUÉBÉC (DCQ): VALIDATION AND NORMATIVE DATA FOR A NOVEL COGNITIVE SCREENING TOOL FOR ATYPICAL DEMENTIAS Alzheimer's & Dementia. 13: P807-P808. DOI: 10.1016/J.Jalz.2017.06.1101 |
0.745 |
|
| 2016 |
Bergeron D, Vermette A, De La Sablonnière J, Cayer AM, Laforce R, Bouchard RW. Finger-to-Nose Test Findings in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27858718 DOI: 10.3233/Jad-160941 |
0.681 |
|
| 2016 |
Pilon MH, Poulin S, Fortin MP, Houde M, Verret L, Bouchard RW, Laforce R. Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study. Neurology (E-Cronicon). 2: 278-286. PMID 27747317 |
0.75 |
|
| 2016 |
Bensaïdane MR, Beauregard JM, Poulin S, Buteau FA, Guimond J, Bergeron D, Verret L, Fortin MP, Houde M, Bouchard RW, Soucy JP, Laforce R. Clinical Utility of Amyloid PET Imaging in the Differential Diagnosis of Atypical Dementias and Its Impact on Caregivers. Journal of Alzheimer's Disease : Jad. PMID 27104896 DOI: 10.3233/Jad-151180 |
0.742 |
|
| 2016 |
Laforce R, Bensaidane MR, Beauregard J, Poulin S, Bergeron D, Verret L, Fortin M, Houde M, Soucy J, Bouchard RW. P2-394: Impact of Disclosing Amyloid Status on Caregivers: A Memory Clinic Study Alzheimer's & Dementia. 12: P796-P796. DOI: 10.1016/J.Jalz.2016.06.1605 |
0.685 |
|
| 2015 |
Bergeron D, Beauregard JM, Guimond J, Fortin MP, Houde M, Poulin S, Verret L, Bouchard RW, Laforce R. Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes. Journal of Alzheimer's Disease : Jad. PMID 26484904 DOI: 10.3233/Jad-150302 |
0.697 |
|
| 2015 |
Callahan BL, Joubert S, Tremblay MP, Macoir J, Belleville S, Rousseau F, Bouchard RW, Verret L, Hudon C. Semantic memory impairment for biological and man-made objects in individuals with amnestic mild cognitive impairment or late-life depression. Journal of Geriatric Psychiatry and Neurology. 28: 108-16. PMID 25344480 DOI: 10.1177/0891988714554708 |
0.462 |
|
| 2015 |
Laforce R, Bensaïdane MR, Bouchard RW, Fortin M, Houde M, Rosa-Neto P, Poulin S, Verret L, Soucy J, Beauregard J. FTS-04-03: Clinical utility of amyloid PET in the differential diagnosis of atypical dementias and its impact on caregivers Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.342 |
0.733 |
|
| 2015 |
Bergeron D, Fortin M, Houde M, Poulin S, Roy M, Verret L, Bouchard RW, Laforce R. P2-197: Dépistage cognitif de québec (DCQ): A novel cognitive screening test for atypical dementias Alzheimer's & Dementia. 11: P568-P568. DOI: 10.1016/J.Jalz.2015.06.736 |
0.743 |
|
| 2015 |
Bensaïdane MR, Bouchard RW, Fortin M, Houde M, Neto PR, Poulin S, Verret L, Soucy J, Beauregard J, Laforce R. P1-173: Clinical utility of amyloid imaging in the differential diagnosis of atypical/unclear dementias and its impact on caregivers Alzheimer's & Dementia. 11: P411-P411. DOI: 10.1016/j.jalz.2015.06.372 |
0.575 |
|
| 2015 |
Bergeron D, Fortin M, Houde M, Poulin S, Verret L, Bouchard RW, Laforce R. P3-212: Distinct rates of cognitive decline associated with normal aging Alzheimer's & Dementia. 11: P713-P714. DOI: 10.1016/J.Jalz.2015.06.1584 |
0.704 |
|
| 2015 |
Bernier PJ, Gourdeau C, Carmichael P, Beauchemin J, Verreault R, Bouchard RW, Kröger E, Laforce R. P3-207: Applying ‘growth curves’ to age-associated cognitive decline: An innovative method to help determine normal versus abnormal longitudinal cognitive changes in the elderly Alzheimer's & Dementia. 11: P711-P712. DOI: 10.1016/J.Jalz.2015.06.1579 |
0.617 |
|
| 2015 |
Bensaïdane MR, Bouchard RW, Fortin M, Houde M, Neto PR, Poulin S, Verret L, Soucy J, Beauregard J, Laforce R. IC-P-007: Clinical utility of amyloid imaging in the differential diagnosis of atypical/unclear dementias and its impact on caregivers Alzheimer's & Dementia. 11: P16-P17. DOI: 10.1016/J.Jalz.2015.06.027 |
0.743 |
|
| 2014 |
Bensaïdane MR, M-P F, Damasse G, Chenard M, Dionne C, Duclos M, Bouchard RW, Laforce R. Clinical Utility of Amyloid Imaging in a Complex Case of Corticobasal Syndrome Presenting with Psychiatric Symptoms. Journal of Neurological Disorders. 2: 1-4. PMID 26225355 DOI: 10.4172/2329-6895.1000194 |
0.591 |
|
| 2014 |
Bergeron D, Verret L, Bouchard RW, Poulin S, Houde M, Fortin M, Laforce R. P2-177: CLINICAL IMPACT OF REPEATED FDG-PET IN THE DIFFERENTIAL DIAGNOSIS OF ATYPICAL DEMENTIAS Alzheimer's & Dementia. 10: P535-P535. DOI: 10.1016/J.Jalz.2014.05.853 |
0.723 |
|
| 2012 |
Macoir J, Hudon C, Bier N, Bouchard R, Houde M, Fortin M, Laforce R, Plante V, Lévesque A. Lexical-Semantic Knowledge about Adjectives is Preserved in Semantic Dementia: Implications for Theoretical Models of Semantic Memory Procedia - Social and Behavioral Sciences. 61: 72-73. DOI: 10.1016/J.Sbspro.2012.10.085 |
0.475 |
|
| 2011 |
Brunet J, Hudon C, Macoir J, Belleville S, Rousseau F, Bouchard RW, Verret L, Chertkow H, Chayer C, Kergoat MJ, Joubert S. The relation between depressive symptoms and semantic memory in amnestic mild cognitive impairment and in late-life depression. Journal of the International Neuropsychological Society : Jins. 17: 865-74. PMID 21729399 DOI: 10.1017/S1355617711000877 |
0.374 |
|
| 2011 |
de Boysson C, Belleville S, Phillips NA, Johns EK, Goupil D, Souchay C, Bouchard R, Chertkow H. False recognition in Lewy-body disease and frontotemporal dementia. Brain and Cognition. 75: 111-8. PMID 21094574 DOI: 10.1016/J.Bandc.2010.10.011 |
0.374 |
|
| 2010 |
Laforce R, Buteau JP, Bouchard JP, Rouleau GA, Bouchard RW, Dupré N. Cognitive impairment in ARCA-1, a newly discovered pure cerebellar ataxia syndrome. Cerebellum (London, England). 9: 443-53. PMID 20559786 DOI: 10.1007/S12311-010-0184-7 |
0.601 |
|
| 2010 |
Laforce R, Buteau JP, Paquet N, Verret L, Houde M, Bouchard RW. The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: A retrospective memory clinic study. American Journal of Alzheimer's Disease and Other Dementias. 25: 324-32. PMID 20539026 DOI: 10.1177/1533317510363468 |
0.684 |
|
| 2008 |
Hsiung GY, Alipour S, Jacova C, Grand J, Gauthier S, Black SE, Bouchard RW, Kertesz A, Loy-English I, Hogan DB, Rockwood K, Feldman HH. Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort. Dementia and Geriatric Cognitive Disorders. 25: 483-90. PMID 18417973 DOI: 10.1159/000126499 |
0.493 |
|
| 2008 |
de Boysson C, Belleville S, Goupil D, Souchay C, Phillips N, Bouchard R. False recognition in persons with mild cognitive impairment, Lewy-body disease and fronto-temporal dementia Brain and Cognition. 67: 15. DOI: 10.1016/J.Bandc.2008.02.023 |
0.487 |
|
| 2007 |
Rockwood K, Bouchard RW, Camicioli R, Léger G. Toward a revision of criteria for the dementias. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 428-40. PMID 19595964 DOI: 10.1016/J.Jalz.2007.07.014 |
0.514 |
|
| 2007 |
Bouchard RW. Diagnostic criteria of dementia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 34: S11-8. PMID 17469675 DOI: 10.1017/S0317167100005497 |
0.505 |
|
| 2007 |
Blair M, Kertesz A, Davis-Faroque N, Hsiung GY, Black SE, Bouchard RW, Gauthier S, Guzman DA, Hogan DB, Rockwood K, Feldman H. Behavioural measures in frontotemporal lobar dementia and other dementias: the utility of the frontal behavioural inventory and the neuropsychiatric inventory in a national cohort study. Dementia and Geriatric Cognitive Disorders. 23: 406-15. PMID 17446701 DOI: 10.1159/000101908 |
0.453 |
|
| 2007 |
Rockwood K, Moorhouse PK, Song X, MacKnight C, Gauthier S, Kertesz A, Montgomery P, Black S, Hogan DB, Guzman A, Bouchard R, Feldman H. Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study. Journal of the Neurological Sciences. 252: 106-12. PMID 17189642 DOI: 10.1016/J.Jns.2006.10.015 |
0.538 |
|
| 2006 |
Hsiung GY, Donald A, Grand J, Black SE, Bouchard RW, Gauthier SG, Loy-English I, Hogan DB, Kertesz A, Rockwood K, Feldman HH. Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias. Dementia and Geriatric Cognitive Disorders. 22: 413-20. PMID 16966831 DOI: 10.1159/000095751 |
0.558 |
|
| 2006 |
Peters KR, Rockwood K, Black SE, Bouchard R, Gauthier S, Hogan D, Kertesz A, Loy-English I, Beattie BL, Sadovnick AD, Feldman HH. Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics. Neurology. 66: 523-8. PMID 16505306 DOI: 10.1212/01.Wnl.0000198255.84842.06 |
0.475 |
|
| 2006 |
Rockwood K, Black SE, Song X, Hogan DB, Gauthier S, MacKnight C, Vandorpe R, Guzman A, Montgomery P, Kertesz A, Bouchard RW, Feldman H. Clinical and radiographic subtypes of vascular cognitive impairment in a clinic-based cohort study. Journal of the Neurological Sciences. 240: 7-14. PMID 16212979 DOI: 10.1016/J.Jns.2005.08.010 |
0.491 |
|
| 2006 |
Sellami L, Meilleur-Durand S, Bergeron D, Verret L, Poulin S, Fortin M, Nadeau Y, Molin P, Macoir J, Hudon C, Bouchard RW, Laforce R. O1-04-06: PREDICTION OF ATYPICAL DEMENTIA SUBTYPES USING A NEW COGNITIVE SCREENING TOOL, THE DÉPISTAGE COGNITIF DE QUÉBEC (DCQ) Alzheimer's & Dementia. 14: P226-P227. DOI: 10.1016/J.Jalz.2018.06.2353 |
0.725 |
|
| 2004 |
Chantal S, Braun CM, Bouchard RW, Labelle M, Boulanger Y. Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Research. 1003: 26-35. PMID 15019560 DOI: 10.1016/J.Brainres.2003.11.074 |
0.44 |
|
| 2003 |
Rockwood K, Davis H, MacKnight C, Vandorpe R, Gauthier S, Guzman A, Montgomery P, Black S, Hogan DB, Kertesz A, Bouchard R, Feldman H. The Consortium to Investigate Vascular Impairment of Cognition: methods and first findings. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 30: 237-43. PMID 12945949 DOI: 10.1017/S0317167100002663 |
0.505 |
|
| 2003 |
Gagnon A, Bouchard RW. Fulminating adult-onset subacute sclerosing panencephalitis in a 49-year-old man. Archives of Neurology. 60: 1160-1. PMID 12925376 DOI: 10.1001/Archneur.60.8.1160 |
0.318 |
|
| 2003 |
Feldman H, Levy AR, Hsiung GY, Peters KR, Donald A, Black SE, Bouchard RW, Gauthier SG, Guzman DA, Hogan DB, Kertesz A, Rockwood K. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology. 22: 265-74. PMID 12902621 DOI: 10.1159/000071189 |
0.529 |
|
| 2002 |
Chantal S, Labelle M, Bouchard RW, Braun CM, Boulanger Y. Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease. Archives of Neurology. 59: 955-62. PMID 12056931 DOI: 10.1001/Archneur.59.6.955 |
0.409 |
|
| 2001 |
Chertkow H, Bergman H, Schipper HM, Gauthier S, Bouchard R, Fontaine S, Clarfield AM. Assessment of suspected dementia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 28: S28-41. PMID 11237308 |
0.443 |
|
| 2000 |
Baladi JF, Bailey PA, Black S, Bouchard RW, Farcnik KD, Gauthier S, Kertesz A, Mohr E, Robillard A. Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications. Clinical Therapeutics. 22: 1549-61. PMID 11192146 DOI: 10.1016/S0149-2918(00)83053-2 |
0.432 |
|
| 2000 |
Rockwood K, Macknight C, Wentzel C, Black S, Bouchard R, Gauthier CS, Feldman H, Hogan D, Kertesz A, Montgomery P. The diagnosis of 'Mixed' dementia in the consortium for the investigation of vascular impairment of cognition (CIVIC) Annals of the New York Academy of Sciences. 903: 522-528. PMID 10818547 DOI: 10.1111/J.1749-6632.2000.Tb06408.X |
0.4 |
|
| 1996 |
Jean H, Emard JF, Thouez JP, Houde L, Robitaille Y, Mathieu J, Boily C, Daoud N, Beaudry M, Cholette A, Bouchard R, Veilleux F, Gauvreau D. Alzheimer's disease: preliminary study of spatial distribution at birth place. Social Science & Medicine (1982). 42: 871-8. PMID 8778999 DOI: 10.1016/0277-9536(95)00185-9 |
0.372 |
|
| 1989 |
Gauthier S, Bouchard R, Bacher Y, Bailey P, Bergman H, Carrier L, Charbonneau R, Clarfield M, Collier B, Dastoor D. Progress report on the Canadian Multicentre Trial of tetrahydroaminoacridine with lecithin in Alzheimer's disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 16: 543-6. PMID 2680009 DOI: 10.1017/S0317167100029899 |
0.414 |
|
| 1987 |
Gauvreau D, Gautrin D, Froda S, Lacoste-Royal G, Braekeleer Md, Bouchard G, Kouladjian K, Gauthier S, Bouchard R, Cholette A, Mathieu J, Boily C, Veillette S, Perron M, Robitaille Y, et al. 77. The IMAGE (Investigations de la Maladie d'Alzheimer: génétique et Epidémiologie) project: a multidimensional approach to Alzheimer's disease Clinical Neurology and Neurosurgery. 89: 28. DOI: 10.1016/0303-8467(87)90077-1 |
0.337 |
|
| 1986 |
Gauthier S, Leblanc R, Robitaille Y, Quirion R, Carlsson G, Beaulieu M, Bouchard R, Dastoor D, Ervin F, Gauthier L. Transmitter-replacement therapy in Alzheimer's disease using intracerebroventricular infusions of receptor agonists. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 394-402. PMID 2878712 DOI: 10.1017/S0317167100036969 |
0.323 |
|
| Show low-probability matches. |